Caesarean Hysterectomy Versus Conservative Management of Placenta Accreta: A Comparative Study
NCT ID: NCT06861972
Last Updated: 2025-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
36 participants
OBSERVATIONAL
2025-04-01
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing Blood Loss During Caesarean Section Between Manual Separation of Placenta & Conservative Management
NCT02480556
A Comparison Between Bladder Dissection Before and After Uterine Incision During Cesarean Section for Placenta Accreta Spectrum: A Randomized Controlled Study
NCT06957184
Sharp Versus Blunt Uterine Incision Expansion
NCT03377894
Role of Uterotonics in Reducing Intraoperative Blood Loss in Patients With PASD Undergoing Cesarean Hysterectomy
NCT06493968
A Comparison of Manual vs. Spontaneous Removal of the Placenta at Cesarean Section
NCT00375986
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Guidelines concerned with PAS management still consider caesarean hysterectomy as the main management of placenta accreta disorders. Owing to the high rate of associated morbidity with caesarean hysterectomy, different researchers are hunting down updated recent management approaches with less morbidity and mortality.
Our study evaluated different outcomes with conservative management of placenta accreta spectrum disorders, namely, focal myometrium resection of the adherent defective myometrium along with its overlying placenta after devascularization, as opposed to caesarean hysterectomy. Data will be observed in a total of 36 PAS patients managed in the OBGYN department, in Kasr Al-Ainy School of medicine hospital, with 18 patients undergoing the previously explained conservative management and 18 patients undergoing caesarean hysterectomy. Demographic data of both study groups, alongside operative time, adjacent organ injury estimated blood loss, need for blood transfusion, Inotropic support and ICU admission will be collected, recorded and analyzed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1 (Caesarean Hysterectomy group)
patients with placenta accreta spectrum undergoing caesarean hysterectomy.
Caesarean Hysterectomy
Caesarean delivery followed by hysterectomy
2 ( Conservative Management group)
patients with placenta accreta spectrum undergoing focal myometrium resection
Conservative management
Focal myometrium resection of the area of diseased myometrium after delivery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Caesarean Hysterectomy
Caesarean delivery followed by hysterectomy
Conservative management
Focal myometrium resection of the area of diseased myometrium after delivery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Average liquor: 5-25 cm
* Gestational age ≥ 34 weeks at time of termination
* Previous lower segment cesarean section/s
* Suspected placenta accreta spectrum.
Exclusion Criteria
* Hemoglobin\< 9.5g/dl
* Ruptured membranes
* Need for emergency delivery as Antepartum hemorrhage or contractions
* Placental abruption
* Lower uterine segment fibroids
* Consent withdrawal
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed ElHarty
Lecturer
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Collins SL, Chantraine F, Morgan TK, Jauniaux E. Abnormally adherent and invasive placenta: a spectrum disorder in need of a name. Ultrasound Obstet Gynecol. 2018 Feb;51(2):165-166. doi: 10.1002/uog.18982. No abstract available.
Nieto-Calvache AJ, Palacios-Jaraquemada JM, Osanan G, Cortes-Charry R, Aryananda RA, Bangal VB, Slaoui A, Abbas AM, Akaba GO, Joshua ZN, Vergara Galliadi LM, Nieto-Calvache AS, Sanin-Blair JE, Burgos-Luna JM; Latin American group for the study of placenta accreta spectrum. Lack of experience is a main cause of maternal death in placenta accreta spectrum patients. Acta Obstet Gynecol Scand. 2021 Aug;100(8):1445-1453. doi: 10.1111/aogs.14163. Epub 2021 May 24.
Jauniaux E, Jurkovic D. Placenta accreta: pathogenesis of a 20th century iatrogenic uterine disease. Placenta. 2012 Apr;33(4):244-51. doi: 10.1016/j.placenta.2011.11.010. Epub 2012 Jan 28.
Related Links
Access external resources that provide additional context or updates about the study.
Kasr Alainy simplified uterine preserving surgery for conservative management of placenta accreta spectrum
Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique
Caesarean hysterectomy
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MD-13-2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.